This is default featured slide 1 title

Find drugs, medications, medical conditions, medication evaluator, latest drug news, vitamins & supplements, pill identifier, first aid resources and many more medicine information with prescription.

This is default featured slide 2 title

Find drugs, medications, medical conditions, medication evaluator, latest drug news, vitamins & supplements, pill identifier, first aid resources and many more medicine information with prescription.

This is default featured slide 3 title

Find drugs, medications, medical conditions, medication evaluator, latest drug news, vitamins & supplements, pill identifier, first aid resources and many more medicine information with prescription.

This is default featured slide 4 title

Find drugs, medications, medical conditions, medication evaluator, latest drug news, vitamins & supplements, pill identifier, first aid resources and many more medicine information with prescription.

This is default featured slide 5 title

Find drugs, medications, medical conditions, medication evaluator, latest drug news, vitamins & supplements, pill identifier, first aid resources and many more medicine information with prescription.

Friday, December 5, 2014

Sex and MS

Multiple Sclerosis Research: Sex and MS: Lew-Starowicz M, Rola R. Correlates of Sexual Function in Male and Female Patients with Multiple Sclerosis. J Sex Med. 2014 Jun. doi: 10.1...

Bronchodilators don't help bronchiolitis



Autumn brings the start of another
Respiratory Syncytial Virus (RSV) season in the U.S., a virus that can
cause bronchiolitis in younger children. The wheezing - and sometimes
decreased oxygen saturation - of bronchiolitis can be scary for parents
and physicians alike; since bronchodilators like albuterol help many
older kids and adults with wheezing, it seems intuitive that they would
help bronchiolitis as well. The November 1 issue of AFP discusses
a Cochrane update, however, demonstrating that bronchodilators don't
improve outcomes in most kids aged less than 2 years with bronchiolitis
.



The Cochrane reviewers found
that, in children less than 24 months old with bronchiolitis who were
wheezing for the first time, bronchodilators didn't improve oxygen
saturation, didn't keep children in the Emergency Department from
getting admitted to the hospital, and didn't reduce the length of stay
in children already admitted to the hospital. Unfortunately,
bronchodilators also caused harm; children who received them were more
likely to have tachycardia and decreased oxygen saturation.



It can be frustrating to see child suffering with bronchiolitis and not be able to offer treatment with a medication, but a recent AFP article on RSV infection reinforces
that no studied pharmaceutical interventions have demonstrated a
meaningful impact on patient-oriented outcomes. Hydration and
supplemental oxygen remain the treatments of choice for the more than 
90,000 children admitted with bronchiolitis in the U.S. every year; fewer children are being admitted in recent years than in the past, but the children who are being admitted are more likely to have high-risk conditions and require mechanical ventilation.





  1. Don't order chest radiographs in children with uncomplicated asthma or bronchiolitis.
  2. Don't routinely use bronchodilators in children with bronchiolitis.
  3. Don't use systemic corticosteroids in children under 2 years of age with an uncomplicated lower respiratory tract infection.




Will this Cochrane review change how you treat young children with bronchiolitis?

BIOMAB: Research Day Antwerp - 24 Oct 2014

BIOMAB: Research Day Antwerp - 24 Oct 2014: Beste Hierbij wensen wij u uit te nodigen op de jaarlijkse onderzoeksdag van de Faculteit Farmaceutische, Biomedische en Diergene...

US Internet Users Don't Need No Stinkin' Mobile Ap...

Pharma Marketing Blog: US Internet Users Don't Need No Stinkin' Mobile Ap...: Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren’t seeing downloa...

Collaborative Manufacturing as a Service in the Cl...

IBM Research: Collaborative Manufacturing as a Service in the Cl...: Editor’s note: This article is by David Breitgand , a team lead at IBM Research – Haifa In the middle of Australian cotton harve...

The Singing Pen of Doctor Jen: Zombies, Run!

The Singing Pen of Doctor Jen: Zombies, Run!: Couch potatoes of the world, you have met your match.  What if your survival depended on your ability to outrun (or out-walk) a zombie horde...

This I believe, Family Medicine-style!

The Singing Pen of Doctor Jen: This I believe, Family Medicine-style!: I was honored to be recognized for the following piece at the FMEC annual meeting this past weekend. The FMEC encourages members to submit ...

FREE Pre-Med Events This Week (9/14-9/20)

US Medical Schools for International Students: FREE Pre-Med Events This Week (9/14-9/20): Hello everyone! Enjoy this week of September with some FREE events, which will come in handy especially if you are getting ready for your M...

Pegylated interferon-beta 2-year follow-up

Multiple Sclerosis Research: Pegylated interferon-beta 2-year follow-up: Is there a need for pegylated interferon? #MSBlog #MSResearch "The study below shows that the effect of long-acting beta-interferon ...

Bariatric surgery for diabetes: does it work?

The AFP Community Blog: Bariatric surgery for diabetes: does it work?: - Jennifer Middleton, MD, MPH I can't remember the last time I referred a patient for weight loss surgery. I precept residents, and I ...

Right-sizing care of patients with serious illness...

The AFP Community Blog: Right-sizing care of patients with serious illness...: - Kenny Lin, MD, MPH Concerned about the overuse of ineffective or harmful practices in older patients with serious illnesses, the High Va...